Heron Therapeutics (HRTX) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts HRTX Hot Sheet
Join SI Premium – FREE
Heron Therapeutics (NASDAQ: HRTX) reported Q1 EPS of ($0.70), $0.02 worse than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Heron Therapeutics (HRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- CarGurus names Matthew Mandel as CFO, effective Oct. 19
- Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
